phase readout
saveNCT06613633: Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC
COMPLETEDupdated 36m ago
community read0 votes
Sponsor: Fudan University. Phase: . Conditions: Third-generation TKI, NSCLC (Advanced Non-small Cell Lung Cancer)
view source ↗
comments(0)
5-min edit window · permanent after that